Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics

Author(s): Wenjia Zhang, Mengrui Liu, Anchang Liu*, Guangxi Zhai*

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 23 , 2017

Become EABM
Become Reviewer
Call for Editor


In recent years, nanocarriers have played increasingly significant roles in cancer therapy. Among various nanoplatforms, mesoporous silica nanoparticles (MSNs) have been given serious attention due to their good colloidal stablity, tunable pore sizes, extensive drug loading capacity and easily modified surface. In this review, functionalized MSNs are introduced as an efficient nanocarrier for cancer treatment. First, MSN preparation strategies are generally introduced. Next, passive and active tumor targeting methods for the functionalization of MSNs are reviewed. Then, several types of stimuli-responsive strategies for on-demand drug release, a wide variety of designs integrating with magnetic resonance imaging agents, optical imaging agents, and positron emission tomography imaging agents, etc. for theranostic purpose are summarized. A discussion relating to the future perspectives of MSNs for clinical translocation is also included in this review.

Keywords: Mesoporous silica nanoparticles, functionalization, tumor targeting, stimuli-responsive, drug delivery, theranostics.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 27 September, 2017
Page: [3367 - 3382]
Pages: 16
DOI: 10.2174/1381612822666161025153619
Price: $65

Article Metrics

PDF: 54